Skip to content

Study held to see the effect of intake of Karkotimool powder in the treatment of Renal calculi.

RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF ââ?¬Å?KARKOTIMOOL CHOORNAââ?¬? IN COMPARISON WITH "VARUNADI KWATHââ?¬Å? IN THE MANAGEMENT OF ââ?¬Å?MOOTRASHMARI ââ?¬? (RENAL CALCULI).

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/029507
Enrollment
60
Registered
2020-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N29- Other disorders of kidney and ureter in diseases classified elsewhere

Interventions

Intervention1: karkotimool choorna: 30 patient will be selected and treated with karkotimool choorna and dose will be 2 gms (Thrice in a day) before meal with ushna jal . Duration of study will be 15

Sponsors

DR JITENDRA KUMAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Size of calculus- A known diagnosed case having renal calculus upto 8 mm. 2)Age group -18 to 60 years with irrespective of gender. 3)Patient of C/O-Udarshool (pain in abdomen), Sadah Mootra Pravrutti (Burning Micturition), Sarakta Mootra Pravrutti (hematuria) will be included. 4)Patients of either sex are taken irrespective of caste, religion and socio-economic status. 5)Though Patients having Mild to Moderate Hydronephrosis will be included in study ( e. Up to the Grade 3 of Hydronephrosis).

Exclusion criteria

Exclusion criteria: 1)Age: below 18 and above 60 years. 2)Systemic diseases like malignancy,Kochââ?¬•s patients and medico-renal disease (M.R.D.) patient. 3)Renal failure, congenital disorder like ectopic kidney, horse shoe kidney, stricture at UV and PU junction, neoplasm. 4)Patients having severe Hydronephrosis/more than mild to moderate (i.e. Grade 4 of Hydronephrosis).

Design outcomes

Primary

MeasureTime frame
1)Mootrashmari is a disease, identified as a global problem. It is a frequent clinical problem with an incidence of 0.1% to 6% in general population. 2)To evaluate and establish safer,cost-effective Karkotimool choorna in the management of Mootra ashmari(Renal Calculi). Timepoint: 15 Days Study (0,7,15 days)

Secondary

MeasureTime frame
Karkotimool choorna is the effective management of Mootrasmari(Renal Calculi)Timepoint: 15 Days with 3 follow up (0,7,15 days)

Countries

India

Contacts

Public ContactDR JITENDRA KUMAR

DR D Y PATIL DEEMED TO BE UNIVERSITY

pbjondhale@gmail.com7499597529

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026